CClinicalTrials.gg
CompletedNCT05653700Updated Dec 4, 2024Results posted

Arena Labs - Improving Clinician Well Being

An interventional study of Arena Strive and Control Cohort in Mental Health Disorder, sponsored by Wake Forest University Health Sciences. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To determine the efficacy of the asynchronous performance coaching platform, Arena Strive at changing measures of physiological resilience, professional fulfillment, burnout, and self-valuation in full time clinicians.

Read the detailed description

This study is a prospective randomized controlled longitudinal crossover design with a per protocol analysis integrating one sensor (WHOOP, inc Platform) and one educational intervention (Arena Strive Platform). The WHOOP sensor collects data on heart rate (HR), heart rate variability (HRV), and sleep data, and will be worn by all participants in the experimental intervention. Participants will be asked to wear the biometric sensor for 12 weeks but will have optional access to the device for a total of 24 weeks.

02

Conditions studied

  • Mental Health Disorder

Browse trials for

Keywords

  • professional fulfillment
  • physiological resilience
  • high-stress environment
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 43 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Employed full time by an Atrium Health affiliated entity
  • Age 18+
  • Willing and able to give written informed consent for study participation
  • Healthcare workers working ≥ 36 hours of clinical duties/week
  • Willingness to wear WHOOP and keep it charged for the entire duration of study
  • Have a smart phone for pairing with WHOOP and the Arena Strive platform

Exclusion criteria

Exclusion Criteria:

  • Current diagnosis of a sleep-related breathing disorder including obstructive sleep apnea not being treated (with or without continuous positive airway pressure (CPAP) treatment)
  • Circadian rhythm sleep-wake disorders
  • Narcolepsy
  • Recurrent isolated sleep paralysis
  • Restless legs syndrome
  • Periodic Leg Movement Disorder
  • Comorbid nocturia or other conditions (benign prostatic hyperplasia) resulting in frequent need to get out of bed to use the bathroom during the night (≥3 times per night average)
  • Atrial Fibrillation
  • Chronic obstructive pulmonary disease (COPD) other than mild, pulmonary fibrosis or severe chronic lung disease
  • Sleep apnea or undergoing treatment for a sleep related illness
  • Lack of availability of iPhone or Android device
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
43 participants (actual)

Study arms

  • Experimental
    Arena Strive

    The experimental intervention employed in this study will be a 12-week, multi-phased approach involving an asynchronous learning and coaching experience (6 weeks), and exploration phase (6 weeks).

    Device: Arena Strive

  • Other
    Control Cohort

    Participants randomized into the control cohort - survey at baseline and end of the study

    Other: Control Cohort

Interventions

  • DeviceArena Strive

    This second-generation platform provides frontline clinicians with a comprehensive journey to access the tools, training, and technology used by other high-pressure fields to increase performance and enhance resilience. The experimental intervention employed in this study will be a 12-week, multi-phased approach involving an asynchronous learning and coaching experience (6 weeks), and exploration phase (6 weeks).

  • OtherControl Cohort

    Participants randomized into the control cohort - survey at baseline and end of the study

06

What researchers measure

Primary outcomes

  1. Change in Heart Rate Variability

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback. Values represent heart rate at specific intervals. The higher the HRV generally the better

    Time frame: Week 16

  2. Change in Resting Heart Rate

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback. The lower heart rate at rest implies more efficient heart function and better cardiovascular fitness.

    Time frame: Week 16

  3. Change in Time Spent in Bed

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

    Time frame: Week 16

  4. Change in Sleep Quality

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

    Time frame: Week 16

  5. Change in Sleep Consistency

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

    Time frame: Week 16

  6. Change in Sleep Debt

    measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

    Time frame: Week 16

  7. Change in Amount of Burn Out (MBI) Malasch Burnout Inventory

    Each item is measured on a scale of 0 to 6 and Total scores range from 0 (less/better burnout) - to 42 (more/worse burnout) - Total score of 17 or less: low level burnout total between 18 and 29 inclusive: moderate burnout total over 30: high-level of burnout

    Time frame: Week 16

  8. Change in Self-reported Professional Fulfillment (PFI)

    collected by means of a survey link at key benchmark moments throughout the intervention period - Each item within PFI scored from 0 to 4 with higher scores being more favorable - scores range from 0 - 24 with higher scores denoting higher fulfillment

    Time frame: Week 16

  9. Change in Self-valuation Scores (Stanford Self-Vaulation)

    collected by means of an in-app survey at key benchmark moments throughout the intervention period - Each item in the self-valuation scale included 4 items measured on a 5-point (0-4) Likert scale lower scores meaning more positivity -scores range from 0 - 16 with lower score denoting more positivity

    Time frame: Week 16

  10. Change in Personal Achievement (MBI)

    "Each Item Measured on a scale of 0 to 6; Total 33 or less: high-level burnout - Total between 34 and 39 inclusive: moderate burnout - Total greater than 40: low-level burnout" Scores range from 0 - 48 with higher scores denoting less burnout

    Time frame: week 16

  11. Change in Depersonalization (MBI)

    "Each item measured on a scale of 0 to 6; total score of 5 or less: low level burnout - total between 6 and 11 inclusive: moderate burnout - total over 12 and greater: high-level of burnout" - scores ranging from 0 - 42 with higher scores denoting more burnout

    Time frame: week 16

  12. Change in Burnout Scores (PFI) - Professional Fulfillment Index

    Scores ranging 0 - 40 with higher scores denoting more exhaustion Likert scale ranging from "not at all" to "extremely" for work exhaustion and interpersonal disengagement item" - lower scores meaning less exhaustion

    Time frame: week 16

Secondary outcomes

  1. Change in Self-reported Satisfaction of the Arena Strive Platform

    collected by means of an in-app survey at key benchmark moments throughout the intervention period - client satisfaction questionnaire 8 (CSQ-8) - Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.

    Time frame: Week 12

  2. Recommendation Score of the Arena Strive Platform

    Net Promoter Score with the question of likelihood to recommend - Net Promoter Score (NPS) is calculated by (promoters-detractors)/total respondents. The range is -100 to 100. The closer you are to 100 the more likely recommend.

    Time frame: Week 12

07

Results

Posted Dec 4, 2024

Participant flow

Participant flow — Overall Study
MilestoneArena StriveControl Cohort
Started2914
Completed2014
Not completed90
Withdrew: Non responders90

Outcome measures

PrimaryChange in Heart Rate Variability

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback. Values represent heart rate at specific intervals. The higher the HRV generally the better

Time frame:
Week 16
Reported as:
Mean · Milliseconds
Change in Heart Rate Variability
MillisecondsArena Strive
Beginning (Week 6)39 (27 to 56)
Mid (Week 12)47 (32 to 65)
End (Week 16)54 (35 to 82)
PrimaryChange in Resting Heart Rate

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback. The lower heart rate at rest implies more efficient heart function and better cardiovascular fitness.

Time frame:
Week 16
Reported as:
Mean · Beats per Minute
Change in Resting Heart Rate
Beats per MinuteArena Strive
Beginning (Week 6)63 (57 to 68)
Mid (Week 12)60 (55 to 65)
End (Week 16)57 (51 to 61)
PrimaryChange in Time Spent in Bed

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

Time frame:
Week 16
Reported as:
Mean · hours
Change in Time Spent in Bed
hoursArena Strive
Beginning (Week 6)7.69 (6.83 to 8.67)
Mid (Week 12)7.60 (6.60 to 8.55)
End (Week 16)7.59 (6.56 to 9.05)
PrimaryChange in Sleep Quality

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

Time frame:
Week 16

No measurements were reported for this outcome.

PrimaryChange in Sleep Consistency

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

Time frame:
Week 16

No measurements were reported for this outcome.

PrimaryChange in Sleep Debt

measured by the WHOOP biometric device - The WHOOP wearable brings hi-tech features including sleep, workout, heart rate feedback and more advanced biometrics in a simple package - the latest, most advanced fitness and health wearable available. Monitor your recovery, sleep, training, and health, with personalized recommendations and coaching feedback.

Time frame:
Week 16

No measurements were reported for this outcome.

PrimaryChange in Amount of Burn Out (MBI) Malasch Burnout Inventory

Each item is measured on a scale of 0 to 6 and Total scores range from 0 (less/better burnout) - to 42 (more/worse burnout) - Total score of 17 or less: low level burnout total between 18 and 29 inclusive: moderate burnout total over 30: high-level of burnout

Time frame:
Week 16
Reported as:
Mean · score on a scale
Change in Amount of Burn Out (MBI) Malasch Burnout Inventory
score on a scaleArena StriveControl Cohort
Week 620 ± 922 ± 9
Week 1217 ± 815 ± 10
Week 1616 ± 1032 ± 6
PrimaryChange in Self-reported Professional Fulfillment (PFI)

collected by means of a survey link at key benchmark moments throughout the intervention period - Each item within PFI scored from 0 to 4 with higher scores being more favorable - scores range from 0 - 24 with higher scores denoting higher fulfillment

Time frame:
Week 16
Reported as:
Mean · score on a scale
Change in Self-reported Professional Fulfillment (PFI)
score on a scaleArena StriveControl Cohort
Week 62.30 ± 0.752.50 ± 0.73
Week 122.58 ± 0.672.14 ± 0.73
Week 162.69 ± 0.992.07 ± 0.74
PrimaryChange in Self-valuation Scores (Stanford Self-Vaulation)

collected by means of an in-app survey at key benchmark moments throughout the intervention period - Each item in the self-valuation scale included 4 items measured on a 5-point (0-4) Likert scale lower scores meaning more positivity -scores range from 0 - 16 with lower score denoting more positivity

Time frame:
Week 16
Reported as:
Mean · score on a scale
Change in Self-valuation Scores (Stanford Self-Vaulation)
score on a scaleArena StriveControl Cohort
Week 65.93 ± 2.426.57 ± 2.59
Week 127.19 ± 2.846.85 ± 2.70
Week 167.60 ± 2.687.64 ± 2.87
PrimaryChange in Personal Achievement (MBI)

"Each Item Measured on a scale of 0 to 6; Total 33 or less: high-level burnout - Total between 34 and 39 inclusive: moderate burnout - Total greater than 40: low-level burnout" Scores range from 0 - 48 with higher scores denoting less burnout

Time frame:
week 16
Reported as:
Mean · score on a scale
Change in Personal Achievement (MBI)
score on a scaleArena StriveControl Cohort
Week 638 ± 835 ± 7
Week 1237 ± 934 ± 7
Week 1637 ± 932 ± 6
PrimaryChange in Depersonalization (MBI)

"Each item measured on a scale of 0 to 6; total score of 5 or less: low level burnout - total between 6 and 11 inclusive: moderate burnout - total over 12 and greater: high-level of burnout" - scores ranging from 0 - 42 with higher scores denoting more burnout

Time frame:
week 16
Reported as:
Mean · score on a scale
Change in Depersonalization (MBI)
score on a scaleArena StriveControl Cohort
Week 615 ± 812 ± 8
week 1211 ± 714 ± 9
Week 1611 ± 815 ± 10
PrimaryChange in Burnout Scores (PFI) - Professional Fulfillment Index

Scores ranging 0 - 40 with higher scores denoting more exhaustion Likert scale ranging from "not at all" to "extremely" for work exhaustion and interpersonal disengagement item" - lower scores meaning less exhaustion

Time frame:
week 16
Reported as:
Mean · score on a scale
Change in Burnout Scores (PFI) - Professional Fulfillment Index
score on a scaleArena StriveControl Cohort
Week 61.54 ± 0.671.56 ± 0.55
Week 121.23 ± 0.631.76 ± 0.63
Week 161.20 ± 0.841.76 ± 0.70
SecondaryChange in Self-reported Satisfaction of the Arena Strive Platform

collected by means of an in-app survey at key benchmark moments throughout the intervention period - client satisfaction questionnaire 8 (CSQ-8) - Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.

Time frame:
Week 12
Reported as:
Mean · score on a scale
Change in Self-reported Satisfaction of the Arena Strive Platform
score on a scaleArena Strive
Change in Self-reported Satisfaction of the Arena Strive Platform25.77 ± 5.45
SecondaryRecommendation Score of the Arena Strive Platform

Net Promoter Score with the question of likelihood to recommend - Net Promoter Score (NPS) is calculated by (promoters-detractors)/total respondents. The range is -100 to 100. The closer you are to 100 the more likely recommend.

Time frame:
Week 12
Reported as:
Mean · score on a scale
Recommendation Score of the Arena Strive Platform
score on a scaleArena Strive
Recommendation Score of the Arena Strive Platform7.45 ± 2.61

Adverse events

Collected over through study completion, an average of 16 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Arena Strive0/29 (0%)0/29 (0%)0/29 (0%)
Control Cohort0/14 (0%)0/14 (0%)0/14 (0%)

Baseline characteristics

Patients were randomized into either control or intervention group (Arena Strive)

Age, Categorical
Age, Categorical(Participants)Arena StriveControl CohortTotal
<=18 years000
Between 18 and 65 years291443
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Arena StriveControl CohortTotal
Female000
Male000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Arena StriveControl CohortTotal
Count of participants——0
08

Study locations

1 site
  • Sanger Heart and Vascular Institute
    Charlotte, North Carolina 28204, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 1, 2023
  • Informed consent form · Mar 1, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (test, tables, figures, and appendices)

Supporting information: Study protocol

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05653700
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Dec 16, 2022
Start date
Mar 16, 2023
Primary completion
Jul 25, 2023
Completion
Jul 25, 2023
Results posted
Dec 4, 2024
Last update
Dec 4, 2024

Study contacts

Kevin Lobdell, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion